MedTrace Logo

Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases

NCT01254240 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2016-05-12

No results posted yet for this study

Summary

This is a double-blind prospective randomized monocenter study comparing the efficacy of two phototherapy ultraviolet spectra on pruritus (itching) of inflammatory skin diseases. 40 patients per treatment, in total 80 study participants.

Conditions

Interventions

DEVICE

UVA / UVB phototherapy

UVA / UVB phototherapy

DEVICE

UVB phototherapy

UVB phototherapy

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Guenther Hofbauer, MD, Leading Physician · University Hospital Zurich, Division of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01254240 on ClinicalTrials.gov